Search research articles
Contact Us
Filters
Showing results (41-50 of 110) with videos related to
Page
of 11
Sort By:
Bioconjugate Chemistry
|
September 1, 2007
A macrophage-nanozyme delivery system for Parkinson's disease
Elena V Batrakova, Shu Li, Ashley D Reynolds, et al.
Clinical Neuroscience Research
|
December 7, 2007
Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease
R Lee Mosley, Eric J Benner, Irena Kadiu, et al.
Neurobiology of Disease
|
January 25, 2020
Immunotherapy for Parkinson's disease
Aaron D Schwab, Mackenzie J Thurston, Jatin Machhi, et al.
Antiviral Research
|
June 1, 2015
Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice
Pavan Puligujja, Mariluz Araínga, Prasanta Dash, et al.
Neuroimmune Pharmacology and Therapeutics
|
February 26, 2024
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson's disease
Milica Markovic, Pravin Yeapuri, Krista L Namminga, et al.
Clinical and Translational Medicine
|
July 8, 2022
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
Mai M Abdelmoaty, Jatin Machhi, Pravin Yeapuri, et al.
Plos One
|
July 24, 2008
Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice
Rebecca Banerjee, R Lee Mosley, Ashley D Reynolds, et al.
Translational Neurodegeneration
|
May 22, 2023
An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
Katherine E Olson, Mai M Abdelmoaty, Krista L Namminga, et al.
Journal of Neuroinflammation
|
May 7, 2018
URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer's disease
Tomomi Kiyota, Jatin Machhi, Yaman Lu, et al.
Journal of Leukocyte Biology
|
October 30, 2025
Regulatory T cell α(1,3)-exofucosylation for treatment of neurodegenerative diseases
Howard E Gendelman, Guoku Hu, Pravin Yeapuri, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 110) with videos related to
Sort By:
Page
of 11
Bioconjugate Chemistry
|
September 1, 2007
A macrophage-nanozyme delivery system for Parkinson's disease
Elena V Batrakova, Shu Li, Ashley D Reynolds, et al.
Clinical Neuroscience Research
|
December 7, 2007
Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease
R Lee Mosley, Eric J Benner, Irena Kadiu, et al.
Neurobiology of Disease
|
January 25, 2020
Immunotherapy for Parkinson's disease
Aaron D Schwab, Mackenzie J Thurston, Jatin Machhi, et al.
Antiviral Research
|
June 1, 2015
Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice
Pavan Puligujja, Mariluz Araínga, Prasanta Dash, et al.
Neuroimmune Pharmacology and Therapeutics
|
February 26, 2024
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson's disease
Milica Markovic, Pravin Yeapuri, Krista L Namminga, et al.
Clinical and Translational Medicine
|
July 8, 2022
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
Mai M Abdelmoaty, Jatin Machhi, Pravin Yeapuri, et al.
Plos One
|
July 24, 2008
Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice
Rebecca Banerjee, R Lee Mosley, Ashley D Reynolds, et al.
Translational Neurodegeneration
|
May 22, 2023
An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
Katherine E Olson, Mai M Abdelmoaty, Krista L Namminga, et al.
Journal of Neuroinflammation
|
May 7, 2018
URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer's disease
Tomomi Kiyota, Jatin Machhi, Yaman Lu, et al.
Journal of Leukocyte Biology
|
October 30, 2025
Regulatory T cell α(1,3)-exofucosylation for treatment of neurodegenerative diseases
Howard E Gendelman, Guoku Hu, Pravin Yeapuri, et al.
Page
of 11